BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24865295)

  • 1. Paliperidone microemulsion for nose-to-brain targeted drug delivery system: pharmacodynamic and pharmacokinetic evaluation.
    Patel MR; Patel RB; Bhatt KK; Patel BG; Gaikwad RV
    Drug Deliv; 2016; 23(1):346-54. PubMed ID: 24865295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of brain targeting efficiency of intranasal microemulsion containing olanzapine: pharmacodynamic and pharmacokinetic consideration.
    Patel RB; Patel MR; Bhatt KK; Patel BG; Gaikwad RV
    Drug Deliv; 2016; 23(1):307-15. PubMed ID: 24845478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microemulsion-based drug delivery system for transnasal delivery of Carbamazepine: preliminary brain-targeting study.
    Patel RB; Patel MR; Bhatt KK; Patel BG; Gaikwad RV
    Drug Deliv; 2016; 23(1):207-13. PubMed ID: 24825492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive intranasal delivery of quetiapine fumarate loaded microemulsion for brain targeting: Formulation, physicochemical and pharmacokinetic consideration.
    Shah B; Khunt D; Misra M; Padh H
    Eur J Pharm Sci; 2016 Aug; 91():196-207. PubMed ID: 27174656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal mucoadhesive microemulsions of clonazepam: preliminary studies on brain targeting.
    Vyas TK; Babbar AK; Sharma RK; Singh S; Misra A
    J Pharm Sci; 2006 Mar; 95(3):570-80. PubMed ID: 16419051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and In-vivo Pharmacokinetic Consideration of Intranasal Microemulsion and Mucoadhesive Microemulsion of Rivastigmine for Brain Targeting.
    Shah B; Khunt D; Misra M; Padh H
    Pharm Res; 2018 Jan; 35(1):8. PubMed ID: 29294189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal nanoemulsion based brain targeting drug delivery system of risperidone.
    Kumar M; Misra A; Babbar AK; Mishra AK; Mishra P; Pathak K
    Int J Pharm; 2008 Jun; 358(1-2):285-91. PubMed ID: 18455333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary brain-targeting studies on intranasal mucoadhesive microemulsions of sumatriptan.
    Vyas TK; Babbar AK; Sharma RK; Singh S; Misra A
    AAPS PharmSciTech; 2006 Jan; 7(1):E8. PubMed ID: 16584167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal mucoadhesive microemulsion of tacrine to improve brain targeting.
    Jogani VV; Shah PJ; Mishra P; Mishra AK; Misra AR
    Alzheimer Dis Assoc Disord; 2008; 22(2):116-24. PubMed ID: 18525282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Nanoemulsion and Aqueous Micelle Systems of Paliperidone for Intranasal Delivery.
    Pidaparthi K; Suares D
    AAPS PharmSciTech; 2017 Jul; 18(5):1710-1719. PubMed ID: 27714701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal mucoadhesive microemulsions of zolmitriptan: preliminary studies on brain-targeting.
    Vyas TK; Babbar AK; Sharma RK; Misra A
    J Drug Target; 2005 Jun; 13(5):317-24. PubMed ID: 16199375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Evaluation of pH-Responsive Cyclodextrin-Based in situ Gel of Paliperidone for Intranasal Delivery.
    Sherje AP; Londhe V
    AAPS PharmSciTech; 2018 Jan; 19(1):384-394. PubMed ID: 28748368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nose-to-brain delivery of tacrine.
    Jogani VV; Shah PJ; Mishra P; Mishra AK; Misra AR
    J Pharm Pharmacol; 2007 Sep; 59(9):1199-205. PubMed ID: 17883890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan and cyclodextrin in intranasal microemulsion for improved brain buspirone hydrochloride pharmacokinetics in rats.
    Bshara H; Osman R; Mansour S; El-Shamy Ael-H
    Carbohydr Polym; 2014 Jan; 99():297-305. PubMed ID: 24274510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model.
    Md S; Khan RA; Mustafa G; Chuttani K; Baboota S; Sahni JK; Ali J
    Eur J Pharm Sci; 2013 Feb; 48(3):393-405. PubMed ID: 23266466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal cabergoline: pharmacokinetic and pharmacodynamic studies.
    Sharma G; Mishra AK; Mishra P; Misra A
    AAPS PharmSciTech; 2009; 10(4):1321-30. PubMed ID: 19894122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal haloperidol-loaded miniemulsions for brain targeting: Evaluation of locomotor suppression and in-vivo biodistribution.
    El-Setouhy DA; Ibrahim AB; Amin MM; Khowessah OM; Elzanfaly ES
    Eur J Pharm Sci; 2016 Sep; 92():244-54. PubMed ID: 27154259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal microemulsion for targeted nose to brain delivery in neurocysticercosis: Role of docosahexaenoic acid.
    Shinde RL; Bharkad GP; Devarajan PV
    Eur J Pharm Biopharm; 2015 Oct; 96():363-79. PubMed ID: 26318978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain targeting of chitosan-based diazepam mucoadhesive microemulsions via nasal route: formulation optimization, characterization, pharmacokinetic and pharmacodynamic evaluation.
    Ramreddy S; Janapareddi K
    Drug Dev Ind Pharm; 2019 Jan; 45(1):147-158. PubMed ID: 30230386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal clobazam delivery in the treatment of status epilepticus.
    Florence K; Manisha L; Kumar BA; Ankur K; Kumar MA; Ambikanandan M
    J Pharm Sci; 2011 Feb; 100(2):692-703. PubMed ID: 20799366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.